FOLH1 and xerostomia: A key to this assessment is to measure the extent of dry mouth in mice during and after [225Ac]Ac-PSMA-1-DOTA therapy, which will require quantification of induced salivation [36], since certain degrees of xerostomia observed clinically is not prominently reflected in histopathological features.